|
|
 |
| OVERVIEW |
| |
|
NYC Bioscience Bulletin provides the latest news and information on the thriving bioscience cluster in New York City. This month's issue highlights news from NYC biopharmaceutical companies and BIO '08.
Visit www.nycbiotech.com or contact us for more information on how New York City Economic Development Corporation (NYCEDC) can assist your business. |
|
| IN THE NEWS |
| |
|
Fovea Raises $44M/Receives Orphan Drug Designation from the European Commission
Fovea Pharmaceuticals, with US offices in New York City, raised $44M in a Series B financing. The company also announced that its product, Recombinant human rod-derived cone viability factor (rh-RdCVF), received designation as Orphan Medicinal Product from the European Commission. Fovea is focused on discovering, developing and commercializing innovative breakthrough drugs for the treatment of retinal diseases.
Press Release > |
 |
|
Ziopharm's ZIO-201 Among 100 Greatest Investigational Drugs
New York City based ZIOPHARM Oncology, Inc. is a biopharmaceutical company engaged in the development and commercialization of cancer drugs to address unmet medical needs. ZIOPHARM recently received FDA orphan drug designation for Palifosfamide (ZIO-201) in the treatment of Soft Tissue Sarcoma. ZIO-201 was also recently honored as being one of the 100 Greatest Investigational Drugs by R&D Directions Magazine. |
|
|
NYC Bioscience Initiative Exhibiting at BIO 2008
Key representatives from New York City Economic Development Corporation's bioscience team will be available for one-on-one meetings at BIO 2008 in the New York Loves Bio pavilion (booth 2444). Participating at the booth as a partner, The New York Academic Consortium will also be available to discuss their recent collaborative activities. Contact Lenzie Harcum to learn more about premier biotech lab space, incentives and the resources making up NYC's thriving bioscience cluster. |
|
|
NYC's SIBL Proves to be a Valuable Resource
Science, Industry and Business Library (SIBL) in NYC is attracting the scientific community with their research databases and trade literature typically found in the nation's top corporations. Biological industries are prominently covered in databases such as Plunkett's, Espicom and Zephyr and contain valuable market research, industry trends, competitive intelligence and company financial information. SIBL is also playing host to key prominent seminars. |
|
|
New York Named to Top Five Biotech Regions
According to the 2008 Top 5 Regions for Biotech report from FierceBiotech, New York is now included as one of the top regions targeting biotech. New York's growing cluster is also home to top researching facilities such as Columbia University Medical Center, Memorial Sloan Kettering and Cornell. With $600 million approved for embryonic an adult stem cell research projects, New York now ranks number two in stem cell research, second only to California. | |
|